Terms And Conditions
  1. Home
  2. Terms And Conditions
Proteomics International Laboratories Ltd (AS...
By ACE Investors / 01 Nov 2021
Read More
BWX Limited: Focus on Expanding product Offer...
By ACE Investors / 01 Nov 2021
Read More
Imugene Limited: Well-Funded to Support Its C...
By ACE Investors / 28 Oct 2021
Read More
Imricor Medical Systems Inc. (ASX: IMR): Exec...
By ACE Investors / 25 Oct 2021
Read More
Repare Therapeutics Inc. (NYSE: RPTX): Dosed ...
By ACE Investors / 21 Oct 2021
Read More
Doctor Care Anywhere Group PLC: UK Primary He...
By ACE Investors / 19 Oct 2021
Read More
Audeara Limited (ASX: AUA): Audeara is focuse...
By ACE Investors / 18 Oct 2021
Read More
MEI Pharma, Inc. (NYSE: MEIP): Topline TIDAL ...
By ACE Investors / 14 Oct 2021
Read More
Micro-X Limited (ASX: MX1): Micro-X Has Secur...
By ACE Investors / 05 Oct 2021
Read More
Cochlear Limited: Delay in Surgeries Likely t...
By ACE Investors / 29 Sep 2021
Read More
Bionomics Limited (ASX: BNO): The ATTUNE Stud...
By ACE Investors / 20 Sep 2021
Read More
NOVONIX Limited (ASX: NVX): Share Price Surge...
By ACE Investors / 15 Sep 2021
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors